Drug-eluting stents more effective than bare-metal stents in heart attack patients
Tuesday, May 26, 2009 - 13:42
in Health & Medicine
NewYork-Presbyterian Hospital and Columbia University Medical Center, together with the Cardiovascular Research Foundation (CRF), announced that its landmark study comparing the safety and efficacy of drug-eluting stents and bare-metal stents was published in the May 7 New England Journal of Medicine. The study, HORIZONS-AMI (Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction), showed that in heart attack patients undergoing angioplasty, the use of paclitaxel-eluting stents reduces rates of target lesion revascularization (TLR) and binary angiographic restenosis when compared to the use of bare-metal stents after one year.
Read the whole article on Physorg
More from Physorg
Related
- Drug-eluting stents prove more effective, equally as safe as bare-metal stentsWed, 6 May 2009, 17:42:54 EDT
- Drug-eluting stents more effective, equally as safe as bare metal stents in clinical trialWed, 15 Oct 2008, 12:22:35 EDT
- NEJM study finds drug-eluting stents more effective than bare-metal stents in heart attack patientsTue, 26 May 2009, 14:43:06 EDT
- Drug-eluting stents better than bare-metal stents for heart attack patientsFri, 25 Sep 2009, 15:35:45 EDT
- Analysis of drug-eluting stents data demonstrates safety, efficacy in on-and-off-label useTue, 16 Jun 2009, 12:45:06 EDT